Gonadotropin.org: Presentations from ASRM 2004


			Presentations from ASRM October 18, 2004 Optimizing the ART Process Now and in the Future: From Gonadotropins to Enhanced Evaluation of Embryonic Development

Presentations

Scott Chappel, PhD

	Recombinant and Urinary Gonadotropins: Comparison of Efficacy, Safety and Consistency
	presented by Scott Chappel, PhD View the video introduction to presentation and view the presentation read the video transcript and read the presentation transcript

Richard P. Marrs, MD

	Human Menopausal Gonadotropin Supplied Luteinizing Hormone Activity - Helpful, Harmful or Necessary?
	presented by Richard P. Marrs, MD View the video introduction to presentation and view the presentation read the video transcript and read the presentation transcript

Richard T. Scott, MD, HCLD

	Evaluation of Embryonic Reproductive Competence
	presented by Richard T. Scott, MD, HCLD View the video introduction to presentation and view the presentation read the video transcript and read the presentation transcript

presentations from prior meetings:

Hind Hatoum, PhD

	A Markov Model of the Cost Effectiveness of Human-Derived FSH versus Recombinant FSH Using Comparative Clinical Trial Data
	presented by Hind Hatoum, PhD view the presentation or read the presentation transcript

William Keye, MD

	Improving the efficacy, safety, cost-effectiveness and acceptability of gonadotropin administration prior to in vitro fertilization
	presented by William Keye, MD view the presentation or read the presentation transcript